Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CXCR4 | P61073 | 6/20 | 0.35 |
| ▸ | NCF1 | P14598 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24513990 | 0.94 | KDM4E (0.41) | KDM4EALDH1A1MAPTPKMTHRB | |
| SCHEMBL24513989 | 0.94 | KDM4E (0.41) | KDM4EALDH1A1MAPTPKMTHRB | |
| SCHEMBL22790759 | 0.88 | KDM4E (0.42) | KDM4EALDH1A1MAPTPKMTHRB | |
| SCHEMBL25109776 | 0.86 | HRH3 (0.46) | KDM4EALDH1A1MAPTPKMTHRB | |
| SCHEMBL22793930 | 0.85 | KDM4E (0.43) | KDM4EALDH1A1MAPTPKMTHRB | |
| SCHEMBL22793929 | 0.84 | KDM4E (0.42) | KDM4EALDH1A1MAPTPKMTHRB | |
| SCHEMBL24514674 | 0.84 | NCF1 (0.45) | KDM4ETHRBTDP1CXCR4NCF1 | |
| SCHEMBL25108854 | 0.83 | KDM4E (0.39) | KDM4EALDH1A1MAPTPKMTDP1 | |
| SCHEMBL25481170 | 0.83 | KDM4E (0.34) | KDM4EALDH1A1MAPTTHRBTDP1 | |
| SCHEMBL22790760 | 0.83 | L3MBTL1 (0.35) | KDM4EALDH1A1MAPTTHRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230072658-A1 | SMARCA DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230072658-A1 | SMARCA DEGRADERS AND USES THEREOF | SMARCA1, SMARCB1, SMARCE1 | KDM4E 624/4885ALDH1A1 3736/4885MAPT 1445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.